Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine

PHASE4CompletedINTERVENTIONAL
Enrollment

1,488

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Malaria
Interventions
DRUG

dihydroartemisinin-piperaquine

Treatment will be given to all malaria-positive individuals on microscopic examination. The dosage will be calculated based on body weight. The drug that will be given is 3-day dihydroartemisinin-piperaquine (DHP) treatment. The drug will be given by health care personnel at their houses assisted by health care volunteers of the integrated health post (Posyandu cadre).

DRUG

primaquine

One day primaquine (PQ) treatment will be given for P. falciparum infected subjects. For patients who are infected by P. vivax and P. ovale,PQ will be given for 14 days

Trial Locations (1)

85762

Kecamatan Wewiku, Betun

All Listed Sponsors
collaborator

Walter and Eliza Hall Institute of Medical Research

OTHER

lead

Indonesia University

OTHER

NCT01878357 - Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine | Biotech Hunter | Biotech Hunter